US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anti-Pandemic Concept

1,344.16

-6.3169-0.47%

Number of Gainers:15

Number of Losers:5

Number of Flat:- -

PE:- -

High:1,358.14

Open:1,352.65

Low:1,337.79

Close:1,350.48

Loading ...

The Aptos community has initiated the "Phased Reduction of Staking Rewards" proposal.

How To Put $100 In Your Retirement Fund Each Month With Johnson & Johnson Stock

Royalty Pharma to Announce First Quarter 2025 Financial Results on May 8, 2025

Press Release: NewAmsterdam Pharma Appoints Adele Gulfo to its Board of Directors

Pfizer (NYSE:PFE) Gets CDC Recommendation to Expand ABRYSVO Vaccine Use for RSV Prevention

Simply Wall St.

Lakeland Industries delays filing of annual 10-K report

Eli Lilly’s Stock Soars After Weight-Loss Pill Competing with Ozempic Shows Promise

Nexus AG Discloses Manager’s Share Sale

Pharma Stock Roundup: J&J's Q1 Results, PFE's Obesity Setback

Abbott Labs Is Maintained at Hold by Jefferies

Nurix Says FDA Clears Oral IRAK4 Degrader Application for Inflammatory Diseases; Shares Up Pre-Bell

MT Newswires Live

Abbott Laboratories : Oppenheimer Raises Target Price to $140 From $134

THOMSON REUTERS

Almonty Industries to Participate in Planet MicroCap Showcase on April 23-24, 2025

BioNTech Se : Leerink Partners Cuts Target Price to $112 From $121

THOMSON REUTERS

BRIEF-Nurix Announces FDA Clearance Of Ind Application For Gs-6791/Nx-0479

Nurix Therapeutics Inc - to Receive $5 Million Milestone Payment From Gilead

THOMSON REUTERS

Bank of America Securities Remains a Buy on BioNTech SE (BNTX)

SAP SE (0NW4): New Buy Recommendation for This Technology Giant

BUZZ-Street View: Abbott's effective management could help it triumph over tariffs

Moderna’s Market Challenges: Hold Rating Amid Regulatory Uncertainty and Competitive Pressures

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4568/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1344.1606,"timestamp":1745438399999,"preClose":1350.4775,"halted":0,"volume":116018608,"delay":0,"changeRate":-0.004678,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-6.316895,"latestTime":"04-23 16:00:00 EDT","open":1352.6482,"high":1358.1393,"low":1337.7921,"amount":5582897091.44565,"amplitude":0.015067,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745452800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.662013,"peRate":24.315362,"turnoverRate":0.007478,"increases":15,"decrements":5,"flats":0,"marketCap":1111877193875.5,"floatMarketCap":1090499613844},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1358.1393,"amplitude":0.015067,"preClose":1350.4775,"low":1337.7921,"pbRate":"3.662013","latestPrice":1344.1606,"volume":116018608,"delay":0,"open":1352.6482,"prevYearClose":1274.8187,"prevWeekClose":1341.7848,"prevMonthClose":1427.887,"prevQuarterClose":1427.887,"fiveDayClose":1326.1057,"twentyDayClose":1396.009,"sixtyDayClose":1358.9425,"secType":"PLATE","market":"US","turnoverRate":0.007478,"peRate":24.315362,"marketCap":1111877193875.5,"floatMarketCap":1090499613844,"timestamp":1745438399999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":15,"down":5,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2528409602","title":"The Aptos community has initiated the \"Phased Reduction of Staking Rewards\" proposal.","url":"https://stock-news.laohu8.com/highlight/detail?id=2528409602","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528409602?lang=en_us&edition=fundamental","pubTime":"2025-04-18 23:39","pubTimestamp":1744990740,"startTime":"0","endTime":"0","summary":"BlockBeats News, April 18th. The Aptos community has initiated the \"Phased Reduction of Staking Rewards\" proposal \"AIP-119,\" suggesting to decrease the staking reward rate from the current approximately 7% to decrease by 1% each month over the next 3 months, ultimately reducing the annualized return rate to 3.79%.Reducing the staking reward rate will help foster the long-term growth of the Aptos ecosystem, particularly encouraging a more active participation in the DeFi space and enhancing the tokenomics of APT to support its sustainable development. As the first step of Aptos's economic model reform, the proposal will undergo community feedback, and if approved, a 6-month observation period will be set up to assess the impact.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/290327","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["APT","BK4568","BK4097","APT.USD.CC","APT.USD.HKCC","AIP","BK4086"],"gpt_icon":0},{"id":"2528700145","title":"How To Put $100 In Your Retirement Fund Each Month With Johnson & Johnson Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2528700145","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528700145?lang=en_us&edition=fundamental","pubTime":"2025-04-18 10:01","pubTimestamp":1744941676,"startTime":"0","endTime":"0","summary":"Johnson & Johnson  engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.It will report its Q1 2025 earnings on April 15. Wall Street analysts expect the company to post EPS of $2.59, down from $2.71 in the prior-year period. According to data from Benzinga Pro, quarterly revenue is expected to be $21.60 billion, up from $21.38 billion a year earlier.Deloitte's fastest-growing software company partners with Amazon, Walmart & Target – Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!Many are using retirement income calculators to check if they’re on pace — here’s a breakdown on what’s behind this formula.The 52-week range of Johnson & Johnson stock price was $140.68 to $169.99.Check out this article by Benzinga for 13 analysts' insights on Johnson & Johnson.How Can You Earn $100 Per Month As A Johnson & Johnson Investor?In summary, income-focused investors may find Johnson & Johnson stock an attract","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/put-100-retirement-fund-month-020116463.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["JNJ","IE0034235303.USD","SG9999002232.USD","US30Y.BOND","US10Y.BOND","BK4568","LU0234572021.USD","LU1162221912.USD","LU0912757837.SGD","LU1732799900.SGD","LU1894683348.USD","IE00BJT1NW94.SGD","LU2112291526.USD","LU1196500208.SGD","LU2129689431.USD","LU0889566641.SGD","LU1244550494.USD","LU1718418525.SGD","IE00BDGV0183.EUR","LU0289739699.SGD","US2Y.BOND","LU1032466523.USD","LU0345769631.USD","BK4504","LU0203347892.USD","US3Y.BOND","LU1261432733.SGD","LU0345770308.USD","LU2592432038.USD","LU2602419157.SGD","LU0882574055.USD","BK4585","LU1221951046.USD","US5Y.BOND","IE0002141913.USD","BK4581","IE00BFTCPJ56.SGD","LU1778281490.HKD","BK4592","IE00BBT3K403.USD","LU0234570918.USD","US12M.BOND","LU1585245621.USD","LU0098860793.USD","IE00B4R5TH58.HKD","US7Y.BOND","US6M.BOND","LU0203345920.USD","BK4550","LU0640476718.USD"],"gpt_icon":0},{"id":"2528477921","title":"Royalty Pharma to Announce First Quarter 2025 Financial Results on May 8, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2528477921","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528477921?lang=en_us&edition=fundamental","pubTime":"2025-04-18 04:15","pubTimestamp":1744920900,"startTime":"0","endTime":"0","summary":"NEW YORK, April 17, 2025  -- Royalty Pharma plc  today announced that it will report its first quarter 2025 financial results on Thursday, May 8, 2025 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:30 a.m. Eastern Time that day.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/royalty-pharma-announce-first-quarter-201500684.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4533","BK4534","LU1894683264.USD","BK4585","IE0002270589.USD","BK4568","SG9999002224.SGD","LU0306806265.USD","BK4581","LU0321505868.SGD","LU0868494617.USD","RPRX","BK4588","LU1883839398.USD","IE00B19Z3581.USD","SG9999001176.USD","SG9999011175.SGD","LU0234572021.USD","LU0058720904.USD","LU1066053197.SGD","SGXZ57979304.SGD","IE000M9KFDE8.USD","BK4007","IE00BBT3K403.USD","LU0321505439.SGD","SG9999013999.USD","BK4550","SG9999002232.USD","LU0456855351.SGD","LU0225771236.USD","BK4599","LU1894683348.USD","LU0225284248.USD","LU0985481810.HKD","IE00B19Z3B42.SGD","LU1066051498.USD","SG9999003800.SGD","LU0289739699.SGD","BK4592","SG9999001176.SGD","LU0306807586.USD","LU0170899867.USD","LU1057294990.SGD","LU1023059063.AUD","IE00BLSP4452.SGD","LU0122379950.USD","IE00BLSP4239.USD"],"gpt_icon":1},{"id":"2528778005","title":"Press Release: NewAmsterdam Pharma Appoints Adele Gulfo to its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2528778005","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528778005?lang=en_us&edition=fundamental","pubTime":"2025-04-18 04:01","pubTimestamp":1744920060,"startTime":"0","endTime":"0","summary":"NAARDEN, the Netherlands and MIAMI, April 17, 2025  -- NewAmsterdam Pharma Company N.V. , a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease  with elevated low-density lipoprotein cholesterol , for whom existing therapies are not sufficiently effective or well-tolerated, today announced the appointment of Adele Gulfo as an independent director to its Board of Directors. Ms. Gulfo is an established pharmaceutical leader with over three decades of experience in the healthcare industry, distinguished by her expertise in global strategy, operations leadership, and the commercialization of multiple blockbuster medicines including LIPITOR and CRESTOR .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4592","IE00BBT3K403.USD","LU0170899867.USD","BK4232","LU0058720904.USD","BK4588","LU0868494617.USD","NAMS","R","LU0306806265.USD","BK4568","LU1894683264.USD","IE00B19Z3B42.SGD","LU0122379950.USD","BK4599","LU0321505868.SGD","IE00B19Z3581.USD","LU0289739699.SGD","LU0225284248.USD","IE00BLSP4452.SGD","SG9999002224.SGD","BK4533","LU0306807586.USD","BK4585","IE00BLSP4239.USD","LU1883839398.USD","LU1057294990.SGD","LU0234572021.USD","LU0985481810.HKD","LU1066053197.SGD","LU1023059063.AUD","SG9999003800.SGD","SG9999011175.SGD","IE000M9KFDE8.USD","IE0002270589.USD","SG9999013999.USD","BK4534","SG9999002232.USD","LU0321505439.SGD","BK4007","SG9999001176.USD","LU0456855351.SGD","SG9999001176.SGD","BK4550","SGXZ57979304.SGD","BK4139","LU1894683348.USD","BK4022","LU1066051498.USD"],"gpt_icon":1},{"id":"2528722823","title":"Pfizer (NYSE:PFE) Gets CDC Recommendation to Expand ABRYSVO Vaccine Use for RSV Prevention","url":"https://stock-news.laohu8.com/highlight/detail?id=2528722823","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528722823?lang=en_us&edition=fundamental","pubTime":"2025-04-18 01:25","pubTimestamp":1744910734,"startTime":"0","endTime":"0","summary":"Pfizer recently received a CDC recommendation for wider use of its RSV vaccine, ABRYSVO, in adults aged 50-59 at increased risk. Despite this positive development, Pfizer's shares saw a 2% decline over the past week. This move is in line with broader market trends, as the market dropped by 3% during the same period. The company's decision to halt development of Danuglipron, an oral weight loss drug, due to safety concerns, may have also added weight to the downward pressure on its shares, amid wider concerns impacting the healthcare sector and investor sentiment surrounding safety in drug development.Pfizer has 3 possible red flags  we think you should know about.The recent CDC recommendation for Pfizer's RSV vaccine, ABRYSVO, is a promising development that could positively impact the company's revenue and earnings forecasts; however, the decision to halt development of the Danuglipron weight loss drug amplifies concerns over safety in drug development. This mix of news, coupled with ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pfizer-nyse-pfe-gets-cdc-172534992.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SG9999003800.SGD","SG9999001176.SGD","LU0225771236.USD","LU0058720904.USD","LU1023059063.AUD","BK4533","LU0985481810.HKD","PFE","SG9999002232.USD","SG9999002224.SGD","IE00B19Z3B42.SGD","BK4007","BK4550","LU0122379950.USD","BK4588","LU0321505868.SGD","LU0306807586.USD","IE00BBT3K403.USD","LU0321505439.SGD","LU0234572021.USD","SG9999001176.USD","BK4585","BK4592","BK4568","LU1066053197.SGD","LU1066051498.USD","CDC","IE00BLSP4452.SGD","IE00BLSP4239.USD","SGXZ57979304.SGD","SG9999013999.USD","LU0868494617.USD","LU1883839398.USD","LU1894683264.USD","BK4534","IE000M9KFDE8.USD","BK4581","LU0456855351.SGD","BK4599","SG9999011175.SGD","LU0170899867.USD","LU0289739699.SGD","IE00B19Z3581.USD","LU0225284248.USD","LU0306806265.USD","NYSE","LU1057294990.SGD","IE0002270589.USD","LU1894683348.USD"],"gpt_icon":1},{"id":"2528072693","title":"Lakeland Industries delays filing of annual 10-K report","url":"https://stock-news.laohu8.com/highlight/detail?id=2528072693","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528072693?lang=en_us&edition=fundamental","pubTime":"2025-04-18 00:40","pubTimestamp":1744908020,"startTime":"0","endTime":"0","summary":"In a regulatory filing, Lakeland Industries (LAKE) reported that the company was unable, without unreasonable effort or expense, to file its Annual...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lakeland-industries-delays-filing-of-annual-10-k-report?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lakeland-industries-delays-filing-of-annual-10-k-report?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B66KJ199.SGD","IE0031619046.USD","IE00B19Z4B17.USD","LAKE","IE00B7SZL793.SGD","BK4568","BK4202"],"gpt_icon":0},{"id":"2528889728","title":"Eli Lilly’s Stock Soars After Weight-Loss Pill Competing with Ozempic Shows Promise","url":"https://stock-news.laohu8.com/highlight/detail?id=2528889728","media":"CoinMarketCap","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528889728?lang=en_us&edition=fundamental","pubTime":"2025-04-17 23:54","pubTimestamp":1744905265,"startTime":"0","endTime":"0","summary":"Neither the author, Tim Fries, nor this website, The Tokenist, provide financial advice. Please consult ourwebsite policyprior to making financial decisions.In a significant advancement for diabetes and weight-loss treatment, Eli Lilly  has unveiled promising trial results for its new oral medication, orforglipron. The experimental pill has shown similar efficacy to the popular injectable drug Ozempic, marking a pivotal moment in the pharmaceutical industry. Following the announcement, Eli Lilly’s shares experienced a notable surge, underscoring the potential impact on the global obesity treatment market. With plans to seek regulatory approval by the end of the year, Eli Lilly is poised to become a dominant player in this lucrative sector. The safety profile of orforglipron aligns with existing GLP-1 class drugs, offering manageable side effects and further solidifying its competitive edge as Pfizer steps back from its rival drug development.Eli Lilly Makes Breakthrough as Global Obesi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://coinmarketcap.com/community/articles/680124385049cc7044ea6893/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"coinmarketcap_highlight","symbols":["LU0122379950.USD","SG9999002224.SGD","LU1066051498.USD","LU2237443895.HKD","LU0289739699.SGD","LLY","LU0823416689.USD","LU0456855351.SGD","LU2361044865.SGD","IE00BLSP4452.SGD","LU1548497426.USD","LU0471298694.HKD","SG9999011175.SGD","LU0466842654.USD","LU0321505868.SGD","IE00BFTCPJ56.SGD","SG9999014914.USD","IE00BBT3K403.USD","SG9999015978.USD","IE00BK4W5M84.HKD","LU1023059063.AUD","BK4568","SGXZ57979304.SGD","LU0225771236.USD","LU1868836757.USD","IE0002270589.USD","SGXZ81514606.USD","SGXZ31699556.SGD","SG9999015945.SGD","LU1883839398.USD","IE00B19Z3B42.SGD","LU0097036916.USD","SG9999017495.SGD","LU2265009873.SGD","LU0868494617.USD","LU0471298777.SGD","BK4588","IE0002141913.USD","LU0058720904.USD","LU1066053197.SGD","LU1057294990.SGD","LU2112291526.USD","LU0106261372.USD","BK4599","IE0009355771.USD","LU1868837136.USD","IE0004445239.USD","BK4516","LU0256863811.USD"],"gpt_icon":1},{"id":"2528741315","title":"Nexus AG Discloses Manager’s Share Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2528741315","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528741315?lang=en_us&edition=fundamental","pubTime":"2025-04-17 22:29","pubTimestamp":1744900140,"startTime":"0","endTime":"0","summary":"NEXUS AG ( ($DE:NXU) ) has issued an announcement. Nexus AG announced a manager’s transaction involving the sale of shares by Andreas Heilig, a per...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nexus-ag-discloses-managers-share-sale?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nexus-ag-discloses-managers-share-sale?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BNTX","BK4139","AG","BK4568","BK4588","BK4535","BK4548","BK4551","BK4210","BK4585"],"gpt_icon":0},{"id":"2528474479","title":"Pharma Stock Roundup: J&J's Q1 Results, PFE's Obesity Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2528474479","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528474479?lang=en_us&edition=fundamental","pubTime":"2025-04-17 21:15","pubTimestamp":1744895700,"startTime":"0","endTime":"0","summary":"J&J JNJ began the earnings season for the drug and biotech sector this week. Pfizer PFE announced the discontinuation of its danuglipron weight loss pill program. The European Commission granted marketing authorization for the expanded use of Roche’s RHHBY cancer drug, Columvi. Sanofi SNY provided an update on its respiratory pipeline.Here's a recap of the week’s most important stories.J&J beat first-quarter estimates for both earnings and sales. Adjusted earnings of $2.77 per share rose 2.2% from the year-ago period. Sales of $21.89 billion rose 2.4% from the year-ago quarter. Innovative Medicines segment sales rose 2.3% year over year to $13.87 billion. MedTech segment sales came in at $8.02 billion, up 2.5% from the year-ago period.The U.S. Centers for Disease Control and Prevention’s  Advisory Committee on Immunization Practices recommended the expanded use of Pfizer and GSK’s respiratory syncytial virus  vaccines, Abrysvo and Arexvy, respectively, in adults aged 50 to 59 at increa","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pharma-stock-roundup-j-js-131500764.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1162221912.USD","IE0002141913.USD","LU1066051225.USD","LU1718418525.SGD","03165","SG9999003800.SGD","LU0058720904.USD","JNJ","IE00BGHQF631.EUR","LU1778281490.HKD","IE00B19Z3581.USD","SG9999001176.USD","IE00B19Z3B42.SGD","BK4550","LU0170899867.USD","LU1066051811.HKD","LU2347655156.SGD","LU2430703178.SGD","LU1244550221.USD","IE00BN8TJ469.HKD","CDC","LU0792757196.USD","BK4581","IE00BFTCPJ56.SGD","IE00BFXG1179.USD","LU0795875169.SGD","IE00BSNM7G36.USD","SG9999001440.SGD","SG9999013999.USD","LU2505996509.AUD","LU1585245621.USD","LU2430703251.USD","IE00BDGV0183.EUR","SNY","LU2430703095.HKD","LU0985320562.USD","LU1244550494.USD","LU0203345920.USD","LU0985481810.HKD","IE00BBT3K403.USD","RHHBY","LU0098860793.USD","LU0122379950.USD","LU2129689605.HKD","LU1032466523.USD","PFE","BK4568","IE00BVYPNV92.GBP","SGXZ57979304.SGD","LU0345769128.USD"],"gpt_icon":1},{"id":"2528085712","title":"Abbott Labs Is Maintained at Hold by Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2528085712","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528085712?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:55","pubTimestamp":1744894500,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ABT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 17, 2025 08:55 ET (12:55 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237957811.SGD","SG9999004303.SGD","LU2237957902.USD","LU1691799644.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","BK4082","LU0122379950.USD","IE00BJT1NW94.SGD","BK4581","LU1721429741.USD","LU2112291526.USD","IE00B2B36J28.USD","BK4592","IE00BJJMRZ35.SGD","SG9999002224.SGD","ABT","IE0009355771.USD","LU0266013472.USD","SG9999002232.USD","IE00B4R5TH58.HKD","BK4585","LU1721429402.USD","LU1989763427.SGD","LU1989763690.USD","SGXZ23171101.USD","IE0002141913.USD","LU1057294990.SGD","BK4588","LU1023059063.AUD","BK4533","BK4566","LU0170899867.USD","LU0234572021.USD","LU1061106388.HKD","LU1914381329.SGD","LU2089984988.USD","LU0868494617.USD","LU2133065610.SGD","BK4504","BK4568"],"gpt_icon":0},{"id":"2528711090","title":"Nurix Says FDA Clears Oral IRAK4 Degrader Application for Inflammatory Diseases; Shares Up Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2528711090","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528711090?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:33","pubTimestamp":1744893215,"startTime":"0","endTime":"0","summary":"Nurix Therapeutics  said Thursday that the US Food and Drug Administration has cleared an investigational new drug application for its oral IRAK4 degrader GS-6791/NX-0479, allowing for a phase 1 trial to start, which is expected to begin in Q2.The company said it is to receive $5 million from Gilead Sciences  for the IND clearance and remains eligible for up to $420 million in potential future milestone payments as part of a 2019 collaboration agreement.Nurix said GS-6791/NX-0479 has potential applications in rheumatology and dermatology, including rheumatoid arthritis and atopic dermatitis.Under the terms of the 2019 collaboration agreement, Nurix and Gilead Sciences  are looking to discover, develop, and commercialize a pipeline of up to five therapies for cancer and other diseases, the company said.Nurix shares were over 8% higher while Gilead shares were 0.2% higher in recent premarket activity.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B19Z3581.USD","IE00BKVL7J92.USD","IE00BSNM7G36.USD","BK4568","BK4578","LU0109394709.USD","LU2089984988.USD","LU0234570918.USD","LU1839511570.USD","LU2468319806.SGD","LU0889565916.HKD","BK4588","BK4550","LU0058720904.USD","LU0289739699.SGD","IE00B19Z3B42.SGD","43A.SI","LU2087621335.USD","BK4585","BK6520","LU1066051498.USD","LU0320765992.SGD","LU1430594728.SGD","LU1066053197.SGD","NRIX","BK4139","IE0002270589.USD","GILD","IE00B7SZLL34.SGD","LU1571399168.USD","BK4566","IE00B3T34201.USD","BK6054","BK4532","IE00BZ1G4Q59.USD","LU1585245621.USD","BK4583"],"gpt_icon":0},{"id":"2528719490","title":"Abbott Laboratories : Oppenheimer Raises Target Price to $140 From $134","url":"https://stock-news.laohu8.com/highlight/detail?id=2528719490","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528719490?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:18","pubTimestamp":1744892284,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nAZN3Q3F2M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4504","IE00BFTCPJ56.SGD","LU1057294990.SGD","IE00BJT1NW94.SGD","LU1721429402.USD","LU1023059063.AUD","SG9999002232.USD","BK4568","LU1061106388.HKD","IE00B4R5TH58.HKD","LU0234572021.USD","BK4581","BK4585","LU0868494617.USD","LU1721429741.USD","LU1989763690.USD","BK4588","LU2237957902.USD","LU0122379950.USD","SGXZ23171101.USD","LU2133065610.SGD","IE00BJJMRZ35.SGD","SG9999002224.SGD","LU2468319806.SGD","IE0002141913.USD","LU2112291526.USD","BK4533","IE00B2B36J28.USD","LU0266013472.USD","SG9999004303.SGD","ABT","BK4566","LU2089984988.USD","LU1989763427.SGD","BK4592","LU1691799644.USD","IE0009355771.USD","LU0170899867.USD","LU2237957811.SGD","LU1914381329.SGD","BK4082"],"gpt_icon":0},{"id":"2528719737","title":"Almonty Industries to Participate in Planet MicroCap Showcase on April 23-24, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2528719737","media":"Business Wire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528719737?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:00","pubTimestamp":1744891200,"startTime":"0","endTime":"0","summary":"TORONTO, April 17, 2025----Almonty Industries Inc.     , a leading global producer of tungsten concentrate, today announced that management has been invited to present at the 2025 Planet MicroCap Showcase taking place in Las Vegas, Nevada on April 23-24, 2025.Business Development and Financial Planning Officer Sophie Frédérique Wind-Veeser is scheduled to host a presentation as well as one-on-one meetings with institutional investors throughout the event as follows:. Lewis Black, President & CEO of Almonty, commented: \"We are pleased to participate in the 2025 Planet MicroCap Showcase as part of our ongoing investor engagement strategy. This comes at an exciting time for Almonty as we approach the operational startup of the Sangdong Tungsten Mine in South Korea and advance our U.S. domestication. With growing global demand for secure tungsten and molybdenum supply chains, Almonty is well-positioned to capitalize on these trends. We look forward to sharing our progress with institutiona","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/almonty-industries-participate-planet-microcap-120000729.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK4168","APT","ALMTF","AII.AU","BK4568","BK4086","APT.AU","BK7095"],"gpt_icon":0},{"id":"2528671599","title":"BioNTech Se : Leerink Partners Cuts Target Price to $112 From $121","url":"https://stock-news.laohu8.com/highlight/detail?id=2528671599","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528671599?lang=en_us&edition=fundamental","pubTime":"2025-04-17 19:44","pubTimestamp":1744890242,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nFWN3QV2N9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4535","BK4585","BK4588","BK4568","BNTX","BK4551","BK4139","BK4548"],"gpt_icon":0},{"id":"2528790993","title":"BRIEF-Nurix Announces FDA Clearance Of Ind Application For Gs-6791/Nx-0479","url":"https://stock-news.laohu8.com/highlight/detail?id=2528790993","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528790993?lang=en_us&edition=fundamental","pubTime":"2025-04-17 19:04","pubTimestamp":1744887869,"startTime":"0","endTime":"0","summary":"BRIEF-Nurix Announces FDA Clearance Of Ind Application For Gs-6791/Nx-0479 April 17 (Reuters) - Nurix Therapeutics Inc NRIX.O:NURIX ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR GS-6791/NX-0479 - A N","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nTUA7XL3YT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00B19Z3B42.SGD","LU1839511570.USD","IE00B7SZLL34.SGD","IE00B3T34201.USD","BK4585","LU0234570918.USD","GILD","LU0889565916.HKD","LU2089984988.USD","LU0289739699.SGD","BK4583","BK4550","IE00BZ1G4Q59.USD","LU1066053197.SGD","BK4139","IE00B19Z3581.USD","LU1066051498.USD","BK4532","LU0109394709.USD","LU1571399168.USD","NRIX","LU2087621335.USD","BK4566","LU1585245621.USD","IE00BSNM7G36.USD","IE00BKVL7J92.USD","LU0058720904.USD","LU1430594728.SGD","LU2468319806.SGD","BK4568","IE0002270589.USD","BK4578","LU0320765992.SGD"],"gpt_icon":0},{"id":"2528797017","title":"Nurix Therapeutics Inc - to Receive $5 Million Milestone Payment From Gilead","url":"https://stock-news.laohu8.com/highlight/detail?id=2528797017","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528797017?lang=en_us&edition=fundamental","pubTime":"2025-04-17 19:00","pubTimestamp":1744887601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nTUA7XL3YT:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GILD","LU0289739699.SGD","BK4532","BK4583","LU1571399168.USD","BK4139","LU0320765992.SGD","IE00BKVL7J92.USD","LU1585245621.USD","LU1066053197.SGD","LU2087621335.USD","LU2089984988.USD","LU1430594728.SGD","BK4585","BK4588","IE00B7SZLL34.SGD","IE00BZ1G4Q59.USD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","IE00B19Z3581.USD","BK4578","LU1839511570.USD","LU0109394709.USD","LU0058720904.USD","BK4568","LU2468319806.SGD","IE0002270589.USD","LU1066051498.USD","BK4566","NRIX","BK4550","LU0889565916.HKD","IE00B3T34201.USD","LU0234570918.USD"],"gpt_icon":0},{"id":"2528740797","title":"Bank of America Securities Remains a Buy on BioNTech SE (BNTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2528740797","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528740797?lang=en_us&edition=fundamental","pubTime":"2025-04-17 18:58","pubTimestamp":1744887513,"startTime":"0","endTime":"0","summary":"In a report released today, Tazeen Ahmad from Bank of America Securities reiterated a Buy rating on BioNTech SE (BNTX – Research Report), with a pr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-remains-a-buy-on-biontech-se-bntx-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-remains-a-buy-on-biontech-se-bntx-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0256863811.USD","IE00B7SZLL34.SGD","LU0306806265.USD","LU1883839398.USD","LU1791807156.HKD","LU1074936037.SGD","BK4207","LU1718418525.SGD","BK4551","IE00BBT3K403.USD","LU0208291251.USD","IE00B19Z3581.USD","LU0648001328.SGD","BK4581","LU0053666078.USD","BK4568","LU0070302665.USD","LU1880398554.USD","LU0971096721.USD","LU1880398471.USD","LU2129689514.USD","IE00BLSP4452.SGD","LU2129689605.HKD","LU0320765489.SGD","LU0417517546.SGD","BNTX","BK4534","LU0314106906.USD","LU1201861165.SGD","LU1280957306.USD","LU1668664300.SGD","LU0868494617.USD","BK4553","LU0106831901.USD","BK4504","IE00BFXG1179.USD","BK4588","LU0310800965.SGD","LU0149725797.USD","LU1894683348.USD","LU0477156797.USD","LU2129689431.USD","LU2133065610.SGD","LU0098860793.USD","LU1366192091.USD","LU0683600562.USD","BK4585","LU0787776722.HKD","IE00BKVL7J92.USD"],"gpt_icon":0},{"id":"2528879125","title":"SAP SE (0NW4): New Buy Recommendation for This Technology Giant","url":"https://stock-news.laohu8.com/highlight/detail?id=2528879125","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528879125?lang=en_us&edition=fundamental","pubTime":"2025-04-17 18:18","pubTimestamp":1744885119,"startTime":"0","endTime":"0","summary":"In a report released today, Andreas Wolf from Warburg Research maintained a Buy rating on SAP SE (0NW4 – Research Report), with a price target of €...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/sap-se-0nw4-new-buy-recommendation-for-this-technology-giant-29?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/sap-se-0nw4-new-buy-recommendation-for-this-technology-giant-29?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BNTX","BK4568","BK4551","BK4139","BK4585","BK4535","BK4548","BK4588"],"gpt_icon":0},{"id":"2528760455","title":"BUZZ-Street View: Abbott's effective management could help it triumph over tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2528760455","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528760455?lang=en_us&edition=fundamental","pubTime":"2025-04-17 17:16","pubTimestamp":1744881378,"startTime":"0","endTime":"0","summary":"BUZZ-Street View: Abbott's effective management could help it triumph over tariffs** Medical device maker Abbott Laboratories ABT.N maintained its annual profit forecast on Wednesday and said it expected U.S. tariffs to hit earnings by a \"few hundred million dollars\"** Median PT of 28 brokerages covering the stock is $145 - LSEG dataOPTIMISM FOR MEDTECH** J.P.Morgan  says it is optimistic about co, citing strong fundamentals and effective management to mitigate tariff impacts** Piper Sandler  says it is confident in co's diversified business model and its ability to navigate through periods of uncertainty while delivering sustainable growth** TD Cowen  sees co mitigating tariff impacts through strategic manufacturing adjustments and leveraging past successes** \"We saw ABT rapidly respond to the COVID pandemic and build a multi billion-dollar Covid testing franchise in very little time. This precedent should give investors confidence that the plant optimization initiatives can succeed i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nL4N3QV0FA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1914381329.SGD","LU2237957811.SGD","IE00B4R5TH58.HKD","BK4581","IE00BJT1NW94.SGD","BK4592","IE00B2B36J28.USD","LU2468319806.SGD","SG9999002224.SGD","SG9999002232.USD","LU1023059063.AUD","LU2089984988.USD","BK4568","SGXZ23171101.USD","BK4082","IE0002141913.USD","LU2237957902.USD","LU0266013472.USD","LU0122379950.USD","ABT","LU1057294990.SGD","LU0868494617.USD","SG9999004303.SGD","LU2112291526.USD","BK4566","BK4585","IE0009355771.USD","LU0234572021.USD","BK4533","LU1691799644.USD","LU1721429402.USD","LU1989763427.SGD","LU2133065610.SGD","BK4504","LU1721429741.USD","BK4588","LU1061106388.HKD","LU0170899867.USD","LU1989763690.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2528505762","title":"Moderna’s Market Challenges: Hold Rating Amid Regulatory Uncertainty and Competitive Pressures","url":"https://stock-news.laohu8.com/highlight/detail?id=2528505762","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528505762?lang=en_us&edition=fundamental","pubTime":"2025-04-17 16:45","pubTimestamp":1744879548,"startTime":"0","endTime":"0","summary":"William Blair analyst Myles Minter has reiterated their neutral stance on MRNA stock, giving a Hold rating on April 14. Myles Minter has given his ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/modernas-market-challenges-hold-rating-amid-regulatory-uncertainty-and-competitive-pressures?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/modernas-market-challenges-hold-rating-amid-regulatory-uncertainty-and-competitive-pressures?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4532","MRNA","BK4588","BK4501","BK4585","BK4568","BK4551","BK4548","BK4533","BK4534"],"gpt_icon":0}],"pageSize":20,"totalPage":14,"pageCount":5,"totalSize":269,"code":"91000000","status":"200"}]}}